Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Insulin Plus Exercise in Type 2 Diabetes
NCT07675499Phase 3Recruiting
- Sponsor
- Rutgers University
- Start
- Aug 2026
- Primary completion
- May 2029
- Countries
- 1
01
Overview
A Phase 3 trial of Generex Oral-lyn in type 2 diabetes mellitus (T2DM), sponsored by Rutgers University. Started Aug 2026; status: recruiting.
02
Drugs
Generex Oral-lyn
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07675499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07675499.